![Mark Morgan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Morgan
Directeur/Bestuurslid bij Dante Labs International LLC
Oorsprong van het eerstegraads netwerk van Mark Morgan
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Dante Labs International LLC
![]() Dante Labs International LLC Miscellaneous Commercial ServicesCommercial Services Dante Labs International LLC engages in provision of genomic tests. The company was founded on May 3, 2017 and is headquartered in New York, NY.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mark Morgan via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Dante Labs, Inc.
![]() Dante Labs, Inc. Medical/Nursing ServicesHealth Services Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY. | Medical/Nursing Services | Chief Executive Officer Director/Board Member | |
Dante Labs Srl
![]() Dante Labs Srl Medical/Nursing ServicesHealth Services Dante Labs Srl provides genetic testing laboratory services. The firm offers sequencing-based genetic tests, including hereditary cancer and cardiovascular disease risk assessment tests directly to consumers in Europe. It has offices in Italy and New York. The company was founded by Mattia Capulli and Andrea Riposati in 2016 and is headquartered in Pizzoli, Italy. | Medical/Nursing Services | Chief Executive Officer | |
Dante Genomics | Chief Executive Officer | ||
ArcherDX LLC
![]() ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Packaged Software | General Counsel | |
Arrogene, Inc.
![]() Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Indiana University | College/University | Undergraduate Degree | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
Indiana University-Purdue University | College/University | Doctorate Degree | |
INVITAE CORPORATION | Medical/Nursing Services | Corporate Officer/Principal | |
Foresight Diagnostics, Inc.
![]() Foresight Diagnostics, Inc. Medical/Nursing ServicesHealth Services Foresight Diagnostics, Inc. is a privately held cancer diagnostics company based in Aurora, CO. The company has developed a liquid biopsy testing platform for the measurement of minimal residual disease (MRD) that is significantly more sensitive than existing tests, with a detection limit below 0.0001% or one part-per-million. This improved sensitivity provides actionable information to physicians and biopharmaceutical companies to enable more personalized treatment approaches for patients with a variety of cancers. The company's experts specialize in liquid biopsy and cancer genomics, developing an MRD assay centered on the detection of ctdna via phased variant sequencing. The company uses phased-seq® liquid biopsy technology for cancer relapse surveillance by monitoring cfdna/ctdna in the blood of lymphoma and lung cancer patients. The company was founded by Maximilian Diehn, Ash Alizadeh, Jake Chabon, and David Kurtz, with Jake Chabon serving as the CEO since incorporation. | Medical/Nursing Services | Chief Operating Officer |
Statistieken
Internationaal
Verenigde Staten | 9 |
Italië | 3 |
Sectoraal
Health Services | 5 |
Consumer Services | 4 |
Technology Services | 2 |
Health Technology | 2 |
Operationeel
Chief Executive Officer | 4 |
Founder | 4 |
Director/Board Member | 2 |
General Counsel | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sterkste connecties
Insiders | |
---|---|
Sandra Close | 9 |
Andrea Riposati | 4 |
- Beurs
- Insiders
- Mark Morgan
- Bedrijfsconnecties